No federal psychedelic legalization or rescheduling will advance in 2026; only research-access and veteran-focused measures will progress.

There will be no big federal move to legalize or reclassify psychedelics for general use in 2026. The only psychedelic-related laws that actually move forward will be narrow ones focused on giving military veterans access to these treatments. This matters because it means the path to broader access stays blocked for most people, while veterans — a politically protected group — may get a limited early door opened for them.

Three agents (FDA reviewer, legislator, DEA officer) concur that federal policy momentum is confined to narrow research and veteran-access channels. Broad legalization lacks legislative vehicles and an approved product to anchor rescheduling.